Pharmaceutical stocks plunge on U.S. credit downgrade

Published: 2011-08-11 07:00:00

Updated: 2011-08-11 07:00:00

Domestic drug firms have seen their stocks plummet over the past several days as retail and foreign investors have dumped shares on the U.S. credit downgrade and fears of a global economic recession.

The benchmark Korea Composite Stock Price Index (KOSPI) dipped as low as 9 percent, dropping b...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK